Literature DB >> 20543576

ERK2/Fra1/ZEB pathway induces epithelial-to-mesenchymal transition.

Sejeong Shin, John Blenis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20543576     DOI： 10.4161/cc.9.13.12270

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  12 in total

Review 1.  MiR-34 and MiR-200: Regulator of Cell Fate Plasticity and Neural Development.

Authors:  Abhishek Jauhari; Sanjay Yadav
Journal:  Neuromolecular Med       Date:  2019-04-08       Impact factor: 3.843

2.  The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.

Authors:  Jane Antony; Elisa Zanini; Zoe Kelly; Tuan Zea Tan; Evdoxia Karali; Mohammad Alomary; Youngrock Jung; Katherine Nixon; Paula Cunnea; Christina Fotopoulou; Andrew Paterson; Sushmita Roy-Nawathe; Gordon B Mills; Ruby Yun-Ju Huang; Jean Paul Thiery; Hani Gabra; Chiara Recchi
Journal:  EMBO Rep       Date:  2018-06-15       Impact factor: 8.807

3.  Xihuang Pill () induces mesenchymal-epithelial transition and inhibits loss of apical-basal polarity in colorectal cancer cell through regulating ZEB1-SCRIB loop.

Authors:  Miao Wang; Jing-yan Meng; Su-fei He
Journal:  Chin J Integr Med       Date:  2014-05-06       Impact factor: 1.978

4.  Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis.

Authors:  Xiaoxiao Gu; Jane J Yu; Didem Ilter; Nickolas Blenis; Elizabeth Petri Henske; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-27       Impact factor: 11.205

5.  ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma.

Authors:  Songtao Qi; Ye Song; Yuping Peng; Hao Wang; Hao Long; Xiaoli Yu; Zhiyong Li; Luxiong Fang; Aibing Wu; Weiren Luo; Yan Zhen; Ying Zhou; Yan Chen; Chunping Mai; Zhen Liu; Weiyi Fang
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

6.  Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.

Authors:  Joseph Cursons; Karl-Johan Leuchowius; Mark Waltham; Eva Tomaskovic-Crook; Momeneh Foroutan; Cameron P Bracken; Andrew Redfern; Edmund J Crampin; Ian Street; Melissa J Davis; Erik W Thompson
Journal:  Cell Commun Signal       Date:  2015-05-15       Impact factor: 5.712

7.  Sphingosylphosphorylcholine Induces Thrombospondin-1 Secretion in MCF10A Cells via ERK2.

Authors:  June Hee Kang; Hyun Ji Kim; Mi Kyung Park; Chang Hoon Lee
Journal:  Biomol Ther (Seoul)       Date:  2017-11-01       Impact factor: 4.634

Review 8.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

9.  ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.

Authors:  Christoforos Thomas; Gayani Rajapaksa; Fotis Nikolos; Ruixin Hao; Anne Katchy; Catherine W McCollum; Maria Bondesson; Phil Quinlan; Alastair Thompson; Savitri Krishnamurthy; Francisco J Esteva; Jan-Åke Gustafsson
Journal:  Breast Cancer Res       Date:  2012-11-16       Impact factor: 6.466

10.  Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug.

Authors:  Poulami Khan; Argha Manna; Shilpi Saha; Suchismita Mohanty; Shravanti Mukherjee; Minakshi Mazumdar; Deblina Guha; Tanya Das
Journal:  BMC Cancer       Date:  2016-01-26       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.